Baker Bros Advisors Lp decreased its stake in Chemocentryx Inc. (CCXI) by 50% based on its latest 2018Q4 regulatory filing with the SEC. Baker Bros Advisors Lp sold 207,000 shares as the company’s stock rose 6.99% with the market. The hedge fund held 207,029 shares of the health care company at the end of 2018Q4, valued at $2.26 million, down from 414,029 at the end of the previous reported quarter. Baker Bros Advisors Lp who had been investing in Chemocentryx Inc. for a number of months, seems to be less bullish one the $690.24 million market cap company. The stock decreased 3.81% or $0.52 during the last trading session, reaching $13.13. About 177,618 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 12.22% since April 13, 2018 and is uptrending. It has outperformed by 7.85% the S&P500. Some Historical CCXI News: 09/03/2018 – ChemoCentryx 4Q Rev $56.3M; 09/03/2018 – CHEMOCENTRYX SEES 2018 CASH & INVESTMENTS USE $65M-$75M; 09/05/2018 – CHEMOCENTRYX INC – QTRLY DILUTED NET LOSS PER COMMON SHARE $0.19; 11/04/2018 – ChemoCentryx Announces Presentation During National Kidney Foundation 2018 Spring Clinical Meeting; 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 23/05/2018 – ChemoCentryx Announces Two Upcoming Presentations at the 55th ERA-EDTA Congress; 09/03/2018 – ChemoCentryx Intends to Initiate Clinical Development of Avacopan in Hidradenitis Suppurativa by Yr-En; 09/03/2018 – CCXI TO BEGIN AVACOPAN CLINICAL STUDIES IN HS BY ’18 END; 09/03/2018 – ChemoCentryx Expects to Utilize Between $65M-$75M Cash and Investments in FY18; 31/03/2018 – ChemoCentryx Conference Set By H.C. Wainwright for Apr. 8-10
Kirr Marbach & Company Llc increased its stake in Cognizant Tech Solution (CTSH) by 2.32% based on its latest 2018Q4 regulatory filing with the SEC. Kirr Marbach & Company Llc bought 4,863 shares as the company’s stock rose 1.41% with the market. The institutional investor held 214,818 shares of the edp services company at the end of 2018Q4, valued at $13.64 million, up from 209,955 at the end of the previous reported quarter. Kirr Marbach & Company Llc who had been investing in Cognizant Tech Solution for a number of months, seems to be bullish on the $42.72 billion market cap company. The stock increased 0.13% or $0.1 during the last trading session, reaching $74.29. About 2.15 million shares traded. Cognizant Technology Solutions Corporation (NASDAQ:CTSH) has declined 11.02% since April 13, 2018 and is downtrending. It has underperformed by 15.39% the S&P500. Some Historical CTSH News: 23/04/2018 – DJ Cognizant Technology Solutions Corp, Inst Holders, 1Q 2018 (CTSH); 16/04/2018 – COGNIZANT AND A CONSORTIUM OF INDIAN LIFE INSURERS ANNOUNCED THAT THEY HAVE DEVELOPED A BLOCKCHAIN SOLUTION TO FACILITATE CROSS-COMPANY DATA-SHARING; 16/04/2018 – Leading Indian Life Insurers Partner with Cognizant to Develop Industry-Wide Blockchain Solution for Secure Data-Sharing and Improved Customer Experience; 12/03/2018 – Cognizant Acquisition of Bolder Healthcare Solutions Expected to Close in 2; 07/05/2018 – Cognizant Tech Solutions 1Q Adj EPS $1.06; 29/03/2018 – Cognizant Named a Leader in Gartner Magic Quadrant for CRM and Customer Experience Implementation Services, Worldwide; 14/05/2018 – IDP Education Partners with Cognizant to Help Students Realise Their International Study and Career Goals; 02/05/2018 – Cognizant Tech Solutions Buys Privately-Held Hedera Consulting for Undisclosed Terms
Since November 15, 2018, it had 0 insider purchases, and 13 selling transactions for $1.51 million activity. 449 shares valued at $30,666 were sold by Friedrich Matthew W. on Friday, December 14. Another trade for 3,013 shares valued at $190,667 was sold by Lennox James Patrick. Another trade for 683 shares valued at $48,650 was sold by Middleton Sean. The insider Telesmanic Robert sold $54,470. $448,683 worth of Cognizant Technology Solutions Corporation (NASDAQ:CTSH) shares were sold by Frank Malcolm. 976 shares were sold by Shaheen Allen, worth $66,592 on Friday, December 14.
Kirr Marbach & Company Llc, which manages about $658.08 million and $360.74 million US Long portfolio, decreased its stake in Canadian Pac Ry Ltd (NYSE:CP) by 28,888 shares to 60,854 shares, valued at $10.81 million in 2018Q4, according to the filing.
More notable recent Cognizant Technology Solutions Corporation (NASDAQ:CTSH) news were published by: Seekingalpha.com which released: “Cognizant: Bullish And Bearish Arguments – Seeking Alpha” on August 27, 2018, also Nasdaq.com with their article: “QQQ, QCOM, CTSH, MU: Large Outflows Detected at ETF – Nasdaq” published on January 04, 2019, Seekingalpha.com published: “Cognizant Technology Solutions Corporation’s (CTSH) Management Presents at Nasdaq’s 39th Investor Conference – (Transcript) – Seeking Alpha” on December 04, 2018. More interesting news about Cognizant Technology Solutions Corporation (NASDAQ:CTSH) were released by: Nasdaq.com and their article: “Cognizant (CTSH) Q4 Earnings Beat Estimates, Revenues Up Y/Y – Nasdaq” published on February 06, 2019 as well as Nasdaq.com‘s news article titled: “What’s in the Cards for Cognizant (CTSH) in Q3 Earnings? – Nasdaq” with publication date: October 24, 2018.
Investors sentiment decreased to 0.83 in Q4 2018. Its down 0.20, from 1.03 in 2018Q3. It fall, as 64 investors sold CTSH shares while 321 reduced holdings. 72 funds opened positions while 248 raised stakes. 482.04 million shares or 2.35% more from 470.99 million shares in 2018Q3 were reported. Naples Limited Liability Corporation accumulated 11,950 shares. First National Bank & Trust holds 0.07% or 5,871 shares in its portfolio. First Interstate Bank & Trust holds 2,133 shares or 0.03% of its portfolio. Guggenheim Capital Ltd Liability Co holds 0.17% of its portfolio in Cognizant Technology Solutions Corporation (NASDAQ:CTSH) for 318,468 shares. Natixis stated it has 567,314 shares. Of Vermont owns 25,341 shares. Richard Bernstein Advsr Lc holds 0.12% in Cognizant Technology Solutions Corporation (NASDAQ:CTSH) or 53,259 shares. Aperio Ltd Llc reported 0.13% in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). Csat Investment Advisory Lp reported 95 shares or 0% of all its holdings. Hbk Investments LP reported 38,600 shares stake. New York-based Clearbridge Invests Lc has invested 0% in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). Gofen Glossberg Limited Liability Corporation Il stated it has 0.01% in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). M Holding Securities Incorporated has 6,862 shares for 0.14% of their portfolio. Robecosam Ag reported 0.35% in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). Cambridge Investment Rech Advsrs reported 21,652 shares or 0.02% of all its holdings.
Baker Bros Advisors Lp, which manages about $8.20B and $12.21 billion US Long portfolio, upped its stake in Clementia Pharmaceuticals Inc. by 1.79M shares to 3.72 million shares, valued at $43.80 million in 2018Q4, according to the filing. It also increased its holding in Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) by 11.27M shares in the quarter, for a total of 39.71 million shares, and has risen its stake in Amarin Corporation Plc (NASDAQ:AMRN).
Investors sentiment decreased to 0.93 in 2018 Q4. Its down 0.05, from 0.98 in 2018Q3. It is negative, as 7 investors sold CCXI shares while 38 reduced holdings. 18 funds opened positions while 24 raised stakes. 27.13 million shares or 1.23% more from 26.80 million shares in 2018Q3 were reported. State Common Retirement Fund holds 25,400 shares. Gp One Trading Ltd Partnership invested in 13,165 shares or 0% of the stock. Acadian Asset Mgmt Ltd Liability Corp holds 818,489 shares or 0.04% of its portfolio. Paw Cap Corp reported 0.68% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Bnp Paribas Arbitrage stated it has 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Adams Diversified Equity Fund Inc holds 0.03% or 38,600 shares in its portfolio. Millennium Mngmt reported 0% stake. Panagora Asset Mngmt holds 0.02% or 324,223 shares. 126,200 are owned by Spark Inv Limited Co. Smith Asset Group Lp has invested 0.01% in ChemoCentryx, Inc. (NASDAQ:CCXI). Dorsey Wright And Assoc has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Vanguard Gru invested in 1.36 million shares or 0% of the stock. Jpmorgan Chase And Co owns 5,738 shares. Fincl Bank Of Montreal Can invested 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Century Incorporated has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI).
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.